HomeSTX • LON
add
Shield Therapeutics PLC
Previous close
GBX 7.15
Day range
GBX 7.00 - GBX 8.40
Year range
GBX 2.10 - GBX 8.40
Market cap
86.23M GBP
Avg Volume
3.94M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 10.72M | 76.78% |
Operating expense | 8.19M | -16.07% |
Net income | -4.77M | 38.40% |
Net profit margin | -44.46 | 65.15% |
Earnings per share | — | — |
EBITDA | -2.54M | 63.29% |
Effective tax rate | -1.68% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.81M | 33.52% |
Total assets | 62.10M | 32.80% |
Total liabilities | 76.96M | 66.50% |
Total equity | -14.86M | — |
Shares outstanding | 953.50M | — |
Price to book | -3.58 | — |
Return on assets | -11.66% | — |
Return on capital | -59.38% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.77M | 38.40% |
Cash from operations | 4.13M | 331.64% |
Cash from investing | -571.50K | -41.29% |
Cash from financing | -1.97M | -107.06% |
Net change in cash | 2.14M | 173.35% |
Free cash flow | -3.29M | 31.77% |
About
CEO
Founded
2008
Website
Employees
63
